AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca accumulated amortisation & impairment of intangible assets ($M) ($M)
Form 20-F Note 10 — Intangible Assets (Inline XBRL)
Latest, FY2025
-45,094
Period ended Dec 31, 2025
Change on a year earlier
+13.5%
-39,736 in FY2024
History
6 years
Since FY2020
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accumulated amortisation & impairment of intangible assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -45,094 | +13.5% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | -39,736 | +12.2% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | -35,400 | +13.0% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | -31,315 | +11.3% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | -28,141 | +9.7% | Form 20-F FY2024 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | -25,660 | – | Form 20-F FY2023 Annual Report ↗ |
Cite this data
StockData. (2026). AstraZeneca Accumulated amortisation & impairment of intangible assets ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/intang_accum_amort
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.